X-118542740-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_144658.4(DOCK11):c.118G>T(p.Val40Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000497 in 1,206,189 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000037 ( 0 hom. 0 hem. )
Consequence
DOCK11
NM_144658.4 missense
NM_144658.4 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
DOCK11 (HGNC:23483): (dedicator of cytokinesis 11) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in several processes, including marginal zone B cell differentiation; positive regulation of GTPase activity; and positive regulation of filopodium assembly. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.30324614).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111129Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33367
GnomAD3 genomes
AF:
AC:
2
AN:
111129
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33367
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000111 AC: 2AN: 180858Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65462
GnomAD3 exomes
AF:
AC:
2
AN:
180858
Hom.:
AF XY:
AC XY:
0
AN XY:
65462
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000365 AC: 4AN: 1095060Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 360578
GnomAD4 exome
AF:
AC:
4
AN:
1095060
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
360578
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111129Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33367
GnomAD4 genome
AF:
AC:
2
AN:
111129
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33367
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.118G>T (p.V40F) alteration is located in exon 2 (coding exon 2) of the DOCK11 gene. This alteration results from a G to T substitution at nucleotide position 118, causing the valine (V) at amino acid position 40 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
0.76
.;P
Vest4
MutPred
Gain of helix (P = 0.062);Gain of helix (P = 0.062);
MVP
MPC
0.57
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at